ALYSSA HEIDERMAN: Open Payments
NPI 1740234137 · BEL AIR, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,178 in 45 payments from 16 companies in 2025. Trend: 2023 $1,200 · 2024 $1,069 · 2025 $1,178
Food & beverage: $1,178
| Company | Payments | Amount |
|---|---|---|
| Saluda Medical Americas, Inc. | 12 | $298 |
| Boston Scientific Corporation | 4 | $209 |
| Collegium Pharmaceutical, Inc. | 5 | $104 |
| Averitas Pharma Inc. | 3 | $90 |
| Abbott Laboratories | 4 | $81 |
| TerSera Therapeutics LLC | 2 | $77 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $60 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $59 |
| BIOTRONIK NRO, Inc. | 2 | $39 |
| MML US, Inc. | 1 | $28 |
Products named: Evoke, WaveWriter Alpha Prime 16, Belbuca, QUTENZA, Prialt, PROCLAIM, RELISTOR, JOURNAVX.
Industry payments across MD — which companies pay providers there.
